Bardia A, Mayer I, Winer E, Linden HM, et al. The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer. Breast Cancer Res Treat 2022 Nov 19. doi: 10.1007/s10549-022-06797.
PMID: 36401732